These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 25955299)
1. Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells. Nishioka C; Ikezoe T; Yang J; Yokoyama A PLoS One; 2015; 10(5):e0125017. PubMed ID: 25955299 [TBL] [Abstract][Full Text] [Related]
2. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells. Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153 [TBL] [Abstract][Full Text] [Related]
3. CD82 regulates STAT5/IL-10 and supports survival of acute myelogenous leukemia cells. Nishioka C; Ikezoe T; Yang J; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A Int J Cancer; 2014 Jan; 134(1):55-64. PubMed ID: 23797738 [TBL] [Abstract][Full Text] [Related]
4. STAT5A regulates DNMT3A in CD34(+)/CD38(-) AML cells. Takeuchi A; Nishioka C; Ikezoe T; Yang J; Yokoyama A Leuk Res; 2015 Aug; 39(8):897-905. PubMed ID: 26059451 [TBL] [Abstract][Full Text] [Related]
5. Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia. Chen J; Li J; Han Q; Sun Z; Wang J; Wang S; Zhao RC Exp Biol Med (Maywood); 2012 Sep; 237(9):1110-6. PubMed ID: 22956625 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells. Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008 [TBL] [Abstract][Full Text] [Related]
7. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells. Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991 [TBL] [Abstract][Full Text] [Related]
8. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo. Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444 [TBL] [Abstract][Full Text] [Related]
9. The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells. Nishioka C; Ikezoe T; Takeuchi A; Nobumoto A; Tsuda M; Yokoyama A Leukemia; 2015 Dec; 29(12):2296-306. PubMed ID: 26260387 [TBL] [Abstract][Full Text] [Related]
10. Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML. Paul TA; Bies J; Small D; Wolff L Blood; 2010 Apr; 115(15):3098-108. PubMed ID: 20190193 [TBL] [Abstract][Full Text] [Related]
11. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express Aurora kinase A. Yang J; Ikezoe T; Nishioka C; Nobumoto A; Udaka K; Yokoyama A Int J Cancer; 2013 Dec; 133(11):2706-19. PubMed ID: 23686525 [TBL] [Abstract][Full Text] [Related]
12. Expression of Enhancer of Zeste Homolog 2 (EZH2) Gene in Acute Myeloid Leukemia. Hamed NAM; El Ghandour A; Abo Elwafa RA; Rezk MR; Ghallab O Asian Pac J Cancer Prev; 2023 Jan; 24(1):81-85. PubMed ID: 36708555 [TBL] [Abstract][Full Text] [Related]
13. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240 [TBL] [Abstract][Full Text] [Related]
14. Global Transcriptome Analysis Reveals That Poly(ADP-Ribose) Polymerase 1 Regulates Gene Expression through EZH2. Martin KA; Cesaroni M; Denny MF; Lupey LN; Tempera I Mol Cell Biol; 2015 Dec; 35(23):3934-44. PubMed ID: 26370511 [TBL] [Abstract][Full Text] [Related]
15. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia. Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294 [TBL] [Abstract][Full Text] [Related]
16. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer. Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy. Sasaki D; Imaizumi Y; Hasegawa H; Osaka A; Tsukasaki K; Choi YL; Mano H; Marquez VE; Hayashi T; Yanagihara K; Moriwaki Y; Miyazaki Y; Kamihira S; Yamada Y Haematologica; 2011 May; 96(5):712-9. PubMed ID: 21228036 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. Chen H; Tu SW; Hsieh JT J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459 [TBL] [Abstract][Full Text] [Related]
19. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer. Lin YW; Ren LL; Xiong H; Du W; Yu YN; Sun TT; Weng YR; Wang ZH; Wang JL; Wang YC; Cui Y; Sun DF; Han ZG; Shen N; Zou W; Xu J; Chen HY; Cao W; Hong J; Fang JY J Pathol; 2013 Jul; 230(3):277-90. PubMed ID: 23424038 [TBL] [Abstract][Full Text] [Related]
20. Lower phosphorylation of p38 MAPK blocks the oxidative stress-induced senescence in myeloid leukemic CD34(+)CD38 (-) cells. Xiao Y; Zou P; Wang J; Song H; Zou J; Liu L J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):328-333. PubMed ID: 22684553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]